James Patrick Nelli Jr. - Dec 13, 2021 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
President
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Dec 13, 2021
Transactions value $
$244,151
Form type
4
Date filed
12/15/2021, 04:07 PM
Previous filing
Dec 7, 2021
Next filing
Feb 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Options Exercise $32.4K +3.04K +2.62% $10.66 119K Dec 13, 2021 Direct
transaction HCAT Common Stock Options Exercise $68.9K +6.5K +5.46% $10.60 125K Dec 13, 2021 Direct
transaction HCAT Common Stock Options Exercise $143K +15.5K +12.33% $9.24 141K Dec 13, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -3.04K -20.12% $0.00 12.1K Dec 13, 2021 Common Stock 3.04K $10.66 Direct F1
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -6.5K -100% $0.00* 0 Dec 13, 2021 Common Stock 6.5K $10.60 Direct F2
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -15.5K -100% $0.00* 0 Dec 13, 2021 Common Stock 15.5K $9.24 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the 15,087 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on April 27, 2021.
F2 25% of the 6,500 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on October 14, 2020.
F3 25% of the 18,500 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on February 10, 2019.